DSGN
Design Therapeutics Inc
13.20$
+4.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | |
| 0.06 | 0.22 | 0.54 | 0.87 | 1.02 | 0.78 | 1.03 | |
| 0.04 | 0.09 | 0.24 | 0.34 | 0.38 | 0.32 | 0.35 | |
| 0.07 | 0.31 | 0.78 | 1.21 | 1.39 | 1.09 | 1.38 | |
| -0.07 | -0.31 | -0.78 | -1.21 | -1.40 | -1.10 | -1.39 | |
| 0.00 | 0.00 | 0.01 | 0.08 | – | – | – | |
| -0.08 | -0.30 | -0.77 | -1.14 | -1.19 | -0.88 | -1.22 | |
| 0.01 | -0.01 | 0.00 | -0.08 | 0.00 | – | – | |
| -0.08 | -0.30 | -0.77 | -1.05 | -1.19 | -0.88 | -1.22 | |
| -0.07 | -0.30 | -0.77 | -1.21 | -1.18 | -0.87 | -1.21 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.